The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10215755 B1

PDF
Full Text
Expired
Date of Patent:
Feb. 26, 2019

Filed:

Oct. 29, 2015
Applicants:

Cfs, Llc, Beverly Hills, MI (US);

Ohio State University, Columbus, OH (US);

Inventors:

A. Martin Lerner, Birmingham, MI (US);

Ronald M. Glaser, Dayton, OH (US);

Assignees:

CFS, LLC, Beverly Hills, MI (US);

OHIO STATE UNIVERSITY, Columbus, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/569 (2006.01); A61K 31/522 (2006.01); A61K 31/52 (2006.01); A61K 31/662 (2006.01); A61K 31/7056 (2006.01);
U.S. Cl.
CPC ...
G01N 33/56994 (2013.01); A61K 31/52 (2013.01); A61K 31/522 (2013.01); A61K 31/662 (2013.01); A61K 31/7056 (2013.01); G01N 2333/05 (2013.01); Y02A 50/401 (2018.01); Y02A 50/402 (2018.01); Y02A 50/57 (2018.01);
Abstract

A method of diagnosing a subset of Epstein Barr Virus, Myalgic Encephalomyelitis Chronic Fatigue Syndrome (ME/CFS) patients through a multi-prong clinical/serological analysis is provided wherein Epstein Barr Virus Abortive Lytic Replication (EBV) is determined as the specific causal agent through the use of serum antibodies to EBV encoded dUTPase and serum antibodies to EBV DNA Polymerase as molecular markers. A method of treating patients diagnosed with Epstein Barr Virus Abortive Lytic Replication (EBV), Myalgic Encephalomyelitis Chronic Fatigue Syndrome (ME/CFS) with specific antiviral nucleosides is also provided, to alleviate the condition.


Find Patent Forward Citations

Quick Actions:

Lerner, A.. (2019). Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients (U.S. Patent No. 10215755). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10215755

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…